Literature DB >> 752766

Evaluation of survival in challenge experiments.

F D Liddell.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 752766      PMCID： PMC281424          DOI： 10.1128/mr.42.1.237-249.1978

Source DB:  PubMed          Journal:  Microbiol Rev        ISSN： 0146-0749


× No keyword cloud information.
  4 in total

1.  The use of survival time in the analysis of neutralization tests for serum antibody surveys.

Authors:  C E G SMITH; D R WESTGARTH
Journal:  J Hyg (Lond)       Date:  1957-06

2.  Precision of potency assay of alum-precipitated tetanus toxoid in mice; an inter-institutional study.

Authors:  J H BROWN; E G GERWE; L GREENBERG; J L HENDRY; J HOHENADEL; P MASUCCI; C NEWMAN; E M TAYLOR
Journal:  J Immunol       Date:  1953-02       Impact factor: 5.422

3.  Resistance of inbred mice to Salmonella typhimurium.

Authors:  H G Robson; S I Vas
Journal:  J Infect Dis       Date:  1972-10       Impact factor: 5.226

4.  Yellow fever vaccination in Malaya by subcutaneous injection and multiple puncture. Neutralizing antibody responses in persons with and without pre-existing antibody to related viruses.

Authors:  C E SMITH; L H TURNER; P ARMITAGE
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408
  4 in total
  16 in total

1.  Effect of treatment with 5-ethyl-2'-deoxyuridine on herpes simplex virus encephalitis in normal and immunosuppressed mice.

Authors:  W B Davis; J E Oakes; J A Taylor
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

2.  Monoclonal antibodies against the fusion protein are protective in necrotizing mumps meningoencephalitis.

Authors:  A Löve; R Rydbeck; G Utter; C Orvell; K Kristensson; E Norrby
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

3.  Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis.

Authors:  J S Wolinsky; M N Waxham; A C Server
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

4.  Efficacy of 2'-nor-2'-deoxyguanosine treatment for orofacial herpes simplex virus type 1 skin infections in mice.

Authors:  M E Davies; J V Bondi; A K Field
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

5.  Mechanisms involved in protection provided by immunization against core lipopolysaccharides of Escherichia coli J5 from lethal Haemophilus pleuropneumoniae infections in swine.

Authors:  B W Fenwick; J S Cullor; B I Osburn; H J Olander
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

6.  Resistance of C3H/HeJ mice to the effects of Haemophilus pleuropneumoniae.

Authors:  B W Fenwick; B I Osburn; H J Olander
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

7.  Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection.

Authors:  J T Rector; R N Lausch; J E Oakes
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

8.  Adoptive transfer of cross-protection among alphaviruses in mice requires allogeneic stimulation.

Authors:  R Peck; C J Wust; A Brown
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

9.  Macrophage dependence of polyriboinosinic acid-polyribocytidylic acid-induced resistance to herpes simplex virus infection in mice.

Authors:  D Martinez; R J Lynch; J B Meeker; A K Field
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

10.  Temperature-modulated immunogenicity to Yersinia pestis from Yersinia enterocolitica O3.

Authors:  J M Alonso; B Hurtrel; D Mazigh; M A Chalvignac; H H Mollaret
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.